CHOP Researchers Develop Tool that Reduces Errors in Stem Cell Transplant Reporting
PHILADELPHIA, Jan. 23, 2023 /PRNewswire/ -- Researchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determination of engraftment, a key outcome after hematopoietic stem cell transplant (HSCT). The application supersedes a tedious manual process and at the same time substantially improves accuracy of reported hematopoietic cell transplant engraftments. The success of the tool, described recently in the journal Transplantation and Cellular Therapy, demonstrates how a unique embedded informatics team can rapidly build and implement applications that are useful in a clinical setting.
- --The tool, developed by hematopoietic cell transplant and informatics collaborators, improved transplant outcomes reporting required by regulators—
PHILADELPHIA, Jan. 23, 2023 /PRNewswire/ -- Researchers at Children's Hospital of Philadelphia (CHOP) have developed a custom-built application to automate determination of engraftment, a key outcome after hematopoietic stem cell transplant (HSCT). - "Our experience building this application could serve as a blueprint for broad implementation of a similar tool, which would improve not only transplant reporting but also transplant research and practice."
- Hematopoietic stem cell (HSC) transplant, also referred to as bone marrow or stem cell transplant, is a complex process used for the treatment of multiple types of malignant and non-malignant diseases in adults and children.
- "Automation of Hematopoietic Cell Transplant Outcomes Reporting Leads to Dramatic Reduction of Errors Reported to Real-World Data Registry," Transplantation and Cellular Therapy, online January 5, 2023, DOI: 10.1016/j.jtct.2022.12.026